VYNE Therapeutics Cash from Operations (TTM) Insights

VYNE Therapeutics Inc (VYNE)

2.89 +0.18 (+6.64%) USD | NASDAQ | May 07, 16:00

2.89 0.00 (0.00%) After-Hours: 19:52

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-25.34M
September 30, 2023	-25.02M
June 30, 2023	-26.99M
March 31, 2023	-25.64M
December 31, 2022	-29.20M
September 30, 2022	-34.41M
June 30, 2022	-44.82M
March 31, 2022	-52.86M
December 31, 2021	-56.37M
September 30, 2021	-71.72M
June 30, 2021	-77.82M
March 31, 2021	-97.42M
December 31, 2020	-137.08M

Date	Value
September 30, 2020	-128.12M
June 30, 2020	-120.86M
March 31, 2020	-99.25M
December 31, 2019	-65.10M
September 30, 2019	-65.30M
June 30, 2019	-61.10M
March 31, 2019	-59.60M
December 31, 2018	-52.73M
September 30, 2018	-46.27M
June 30, 2018	-46.62M
March 31, 2018	-33.84M
December 31, 2017	-28.22M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-137.08M

Minimum

Dec 2020

-25.02M

Maximum

Sep 2023

-65.50M

Average

-61.10M

Median

Jun 2019

Cash from Operations (TTM) Benchmarks